Metabolomic signature of exposure and response to citalopram/escitalopram in depressed outpatients.


Journal

Translational psychiatry
ISSN: 2158-3188
Titre abrégé: Transl Psychiatry
Pays: United States
ID NLM: 101562664

Informations de publication

Date de publication:
04 07 2019
Historique:
received: 05 09 2018
accepted: 29 04 2019
revised: 29 03 2019
entrez: 6 7 2019
pubmed: 6 7 2019
medline: 7 2 2020
Statut: epublish

Résumé

Metabolomics provides valuable tools for the study of drug effects, unraveling the mechanism of action and variation in response due to treatment. In this study we used electrochemistry-based targeted metabolomics to gain insights into the mechanisms of action of escitalopram/citalopram focusing on a set of 31 metabolites from neurotransmitter-related pathways. Overall, 290 unipolar patients with major depressive disorder were profiled at baseline, after 4 and 8 weeks of drug treatment. The 17-item Hamilton Depression Rating Scale (HRSD

Identifiants

pubmed: 31273200
doi: 10.1038/s41398-019-0507-5
pii: 10.1038/s41398-019-0507-5
pmc: PMC6609722
doi:

Substances chimiques

Serotonin Uptake Inhibitors 0
Citalopram 0DHU5B8D6V

Types de publication

Clinical Trial Journal Article Research Support, N.I.H., Extramural Research Support, Non-U.S. Gov't Research Support, U.S. Gov't, Non-P.H.S.

Langues

eng

Sous-ensembles de citation

IM

Pagination

173

Subventions

Organisme : NIGMS NIH HHS
ID : U19 GM061388
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG046171
Pays : United States
Organisme : NIGMS NIH HHS
ID : U54 GM114838
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM008685
Pays : United States
Organisme : NIA NIH HHS
ID : U01 AG061359
Pays : United States
Organisme : NIA NIH HHS
ID : RF1 AG051550
Pays : United States
Organisme : NIGMS NIH HHS
ID : T32 GM072474
Pays : United States
Organisme : NIMH NIH HHS
ID : R01 MH108348
Pays : United States
Organisme : NIGMS NIH HHS
ID : R01 GM028157
Pays : United States

Références

Clin Pharmacol Ther. 2011 Jan;89(1):97-104
pubmed: 21107318
Toxins (Basel). 2014 Mar 04;6(3):934-49
pubmed: 24599232
J Clin Psychiatry. 1999 Mar;60(3):142-56
pubmed: 10192589
Pharmacogenomics J. 2013 Oct;13(5):456-63
pubmed: 22907730
Transl Psychiatry. 2018 Jan 10;8(1):10
pubmed: 29317604
Neuropsychopharmacology. 2009 Jan;34(1):173-86
pubmed: 18843269
Transl Psychiatry. 2011;1:
pubmed: 22162828
Clin Pharmacol Ther. 2015 Jul;98(1):71-5
pubmed: 25871646
Neuropharmacology. 2013 Apr;67:476-84
pubmed: 23261866
Free Radic Biol Med. 2014 Oct;75 Suppl 1:S33-4
pubmed: 26461345
Curr Med Chem. 2003 Aug;10(16):1581-91
pubmed: 12871129
Annu Rev Pharmacol Toxicol. 2008;48:653-83
pubmed: 18184107
J Clin Psychopharmacol. 2014 Jun;34(3):313-7
pubmed: 24743713
Mol Psychiatry. 2007 Oct;12(10):934-45
pubmed: 17440431
Psychol Med. 1974 May;4(2):164-73
pubmed: 4829609
Sci Rep. 2016 Oct 12;6:35317
pubmed: 27731396
Mol Psychiatry. 2001 Jul;6(4):475-80
pubmed: 11443537
Cell. 2011 Oct 28;147(3):629-40
pubmed: 21999944
Nat Genet. 2014 Jun;46(6):543-550
pubmed: 24816252
Drug Metab Dispos. 2015 Oct;43(10):1522-35
pubmed: 26041783
PLoS One. 2013 Jul 17;8(7):e68283
pubmed: 23874572
Bioinformatics. 2006 May 1;22(9):1096-102
pubmed: 16481333
J Affect Disord. 2007 Sep;102(1-3):65-72
pubmed: 17270276
PLoS Med. 2006 Aug;3(8):e327
pubmed: 16933966
Mol Nutr Food Res. 2013 Mar;57(3):523-35
pubmed: 23349065
Annu Rev Pharmacol Toxicol. 1999;39:19-52
pubmed: 10331075
J Psychiatr Res. 2015 Sep;68:316-28
pubmed: 26028548
Gigascience. 2015 Feb 25;4:7
pubmed: 25722852
Arch Gen Psychiatry. 2008 Aug;65(8):870-80
pubmed: 18678792
BMC Nephrol. 2016 Nov 10;17(1):171
pubmed: 27832762
J Neurosci. 2002 Nov 15;22(22):10046-52
pubmed: 12427862
Nature. 2011 Jan 20;469(7330):419-23
pubmed: 21248850
Focus (Am Psychiatr Publ). 2018 Apr;16(2):124-134
pubmed: 31975907
Gut Microbes. 2016 May 3;7(3):246-61
pubmed: 27007819
J Affect Disord. 2018 Jun;233:3-14
pubmed: 28709695
Clin Biochem. 2012 Jan;45(1-2):49-53
pubmed: 22040815
N Engl J Med. 2006 Mar 23;354(12):1231-42
pubmed: 16554525
Metabolomics. 2016 Jul;12(7):
pubmed: 27516730
Indian J Clin Biochem. 2010 Jan;25(1):77-81
pubmed: 23105889
Prog Neuropsychopharmacol Biol Psychiatry. 2005 Feb;29(2):201-17
pubmed: 15694227
J Psychopharmacol. 2008 Jun;22(4):343-96
pubmed: 18413657
Nat Rev Drug Discov. 2002 Aug;1(8):609-20
pubmed: 12402501
Nature. 2017 Feb 9;542(7640):242-245
pubmed: 28146477
Nature. 1974 Dec 6;252(5483):490-1
pubmed: 4431474
PLoS Genet. 2009 Jun;5(6):e1000529
pubmed: 19543373
Ann Intern Med. 2007 Oct 16;147(8):573-7
pubmed: 17938396
EMBO Mol Med. 2013 Oct;5(10):1465-83
pubmed: 24039130
Mol Psychiatry. 2016 Dec;21(12):1717-1725
pubmed: 26903268
Int J Neuropsychopharmacol. 2007 Aug;10(4):557-63
pubmed: 17291371
Psychiatry Res. 2015 Jun 30;227(2-3):206-12
pubmed: 25865484
PLoS One. 2013;8(3):e57639
pubmed: 23536766
J Child Psychol Psychiatry. 2010 Aug;51(8):935-43
pubmed: 20406333
Br J Clin Pharmacol. 2014 Aug;78(2):373-83
pubmed: 24528284
Sci Rep. 2012;2:667
pubmed: 22993692
Adv Exp Med Biol. 1996;398:285-9
pubmed: 8906279
Clin Pharmacol Ther. 2014 Feb;95(2):154-67
pubmed: 24193171
Nucleosides Nucleotides Nucleic Acids. 2008 Jun;27(6):608-19
pubmed: 18600514
Clin Pharmacol Ther. 2013 Oct;94(4):525-32
pubmed: 23839601
Int J Geriatr Psychiatry. 2007 May;22(5):418-23
pubmed: 17048218
Psychoneuroendocrinology. 2016 Aug;70:25-32
pubmed: 27153521
Neuron. 2013 Oct 16;80(2):429-41
pubmed: 24139043
Ann Clin Transl Neurol. 2015 Jul;2(7):756-68
pubmed: 26273688
Nature. 2018 May;557(7707):724-728
pubmed: 29769726
N Engl J Med. 2012 Jan 12;366(2):181-3
pubmed: 22236230
PLoS One. 2017 Jun 8;12(6):e0174035
pubmed: 28594839
Nature. 2015 Oct 1;526(7571):68-74
pubmed: 26432245
Kidney Int Suppl. 2009 Dec;(114):S12-9
pubmed: 19946322
Metabolomics. 2018 Sep 20;14(10):128
pubmed: 30830398
Neuropsychopharmacology. 2006 Sep;31(9):1841-53
pubmed: 16794566
Vasc Health Risk Manag. 2009;5(1):265-72
pubmed: 19436671
BMC Psychiatry. 2016 Apr 18;16:106
pubmed: 27091189
Transl Psychiatry. 2016 Sep 20;6(9):e894
pubmed: 27648916
J Nerv Ment Dis. 2017 Aug;205(8):641-646
pubmed: 27668354
Brain Res. 2006 Feb 16;1073-1074:25-37
pubmed: 16448631
Am J Psychiatry. 2006 Nov;163(11):1905-17
pubmed: 17074942
Nat Med. 2016 Jun;22(6):586-97
pubmed: 27158906
J Affect Disord. 2014 Aug;165:131-4
pubmed: 24882190
BMC Syst Biol. 2011 Jan 31;5:21
pubmed: 21281499
Nat Methods. 2013 Jan;10(1):5-6
pubmed: 23269371
Clin Chem. 1984 Sep;30(9):1477-88
pubmed: 6147209
Psychiatry Res. 1983 Jul;9(3):179-89
pubmed: 6578531
Altern Med Rev. 2008 Sep;13(3):216-26
pubmed: 18950248

Auteurs

Sudeepa Bhattacharyya (S)

Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Ahmed T Ahmed (AT)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Matthias Arnold (M)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA.
Institute of Bioinformatics and Systems Biology, Helmholtz Zentrum München - German Research Center for Environmental Health, Neuherberg, Germany.

Duan Liu (D)

Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Chunqiao Luo (C)

Department of Biomedical Informatics, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

Hongjie Zhu (H)

Sanofi, Bridgewater, NJ, USA.

Siamak Mahmoudiandehkordi (S)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA.

Drew Neavin (D)

Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Gregory Louie (G)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA.

Boadie W Dunlop (BW)

Department of Psychiatry and Behavioral Sciences, Emory University School of Medicine, Atlanta, GA, USA.

Mark A Frye (MA)

Department of Psychiatry and Psychology, Mayo Clinic, Rochester, MN, USA.

Liewei Wang (L)

Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Richard M Weinshilboum (RM)

Department of Molecular Pharmacology & Experimental Therapeutics, Mayo Clinic, Rochester, MN, USA.

Ranga R Krishnan (RR)

Department of Psychiatry, Rush University Medical Center, Chicago, IL, USA.

A John Rush (AJ)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA.
Texas Tech University, Health Sciences Center, Permian Basin, Odessa, TX, USA.
Duke-National University of Singapore, Singapore, Singapore.

Rima Kaddurah-Daouk (R)

Department of Psychiatry and Behavioral Sciences, Duke University School of Medicine, Durham, Durham, NC, USA. rima.kaddurahdaouk@dm.duke.edu.
Department of Medicine, Duke University, Durham, NC, USA. rima.kaddurahdaouk@dm.duke.edu.
Duke Institute of Brain Sciences, Duke University, Durham, NC, USA. rima.kaddurahdaouk@dm.duke.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH